PubRank
Search
About
G Ogg
Author PubWeight™ 42.61
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS.
Nat Med
1997
12.26
2
Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses.
J Exp Med
2001
6.51
3
Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children.
J Exp Med
2000
2.31
4
Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine.
Vaccine
2000
1.71
5
Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection.
Proc Natl Acad Sci U S A
1996
1.68
6
Pathogenesis of severe dengue infection.
Ceylon Med J
2012
1.49
7
T cells reactive with the NC16A domain of BP180 are present in vulval lichen sclerosus and lichen planus.
J Eur Acad Dermatol Venereol
2009
1.46
8
Optimization of a peptide-based protocol employing IL-7 for in vitro restimulation of human cytotoxic T lymphocyte precursors.
J Immunol Methods
1997
1.39
9
Cellular and humoral antigenic epitopes in HIV and SIV.
Immunology
1992
1.38
10
Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors.
Immunol Lett
1999
1.32
11
Memory CD8+ T cells in HIV infection.
Philos Trans R Soc Lond B Biol Sci
2000
1.15
12
Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells.
J Immunol
1999
0.98
13
Stability of empty and peptide-loaded class II major histocompatibility complex molecules at neutral and endosomal pH: comparison to class I proteins.
Proc Natl Acad Sci U S A
1997
0.95
14
An antigenic threshold for maintaining human immunodeficiency virus type 1-specific cytotoxic T lymphocytes.
Mol Med
2000
0.94
15
The dynamics of the cellular immune response to HIV infection: implications for vaccination.
Philos Trans R Soc Lond B Biol Sci
2000
0.92
16
Vancomycin-induced linear IgA disease with autoantibodies to BP180 and LAD285.
Br J Dermatol
2001
0.88
17
Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes.
Nature
1989
0.86
18
Induction of viral and tumour specific CTL responses using antibody targeted HLA class I peptide complexes.
Br J Cancer
2002
0.83
19
Identification of serotype-specific T cell responses to highly conserved regions of the dengue viruses.
Clin Exp Immunol
2012
0.81
20
Defining the T cell antigen proteome of wasp venom.
Clin Exp Allergy
2006
0.79
21
Molecular characterisation of varicella zoster virus genotypes in Sri Lanka.
Ceylon Med J
2013
0.76
22
Filaggrin null mutations associate with increased frequencies of allergen-specific CD4+ T-helper 2 cells in patients with atopic eczema.
Br J Dermatol
2010
0.76
23
HIV clearance in infants.
Lancet
1996
0.75
24
Spontaneous resolution of basal cell carcinoma in naevoid basal cell carcinoma syndrome/Gorlin's syndrome.
Clin Exp Dermatol
2009
0.75
25
Acetylator phenotype, nitrazepam plasma concentrations and residual effects [proceedings].
Br J Clin Pharmacol
1980
0.75
26
Frequencies of circulating allergen-specific T cells temporally associate with longitudinal changes in severity of cutaneous atopic disease.
Clin Exp Dermatol
2010
0.75